CMV-specific T-Cells for treatment of CMV infection after hematopoietic stem cell transplantation in a pediatric case: first application in Turkey
dc.contributor.author | Celilova, Sevil | |
dc.contributor.author | Toret, Ersin | |
dc.contributor.author | Aksoy, Başak | |
dc.contributor.author | Ovalı, Ercüment | |
dc.contributor.author | Bozkurt, Ceyhun | |
dc.date.accessioned | 2021-05-15T12:55:34Z | |
dc.date.available | 2021-05-15T12:55:34Z | |
dc.date.issued | 2020 | |
dc.department | Tıp Fakültesi, Çocuk Hematoloji-Onkoloji ve Kemik İliği Anabilim Dalı | en_US |
dc.description.abstract | Cytomegalovirus (CMV) infection is still a major complication after allogeneic hematopoietic stem cell transplantation (HSCT) [1,2]. Unfortunately, prolonged antiviral treatment of CMV infection causes a delayed CMV-specific immune reconstitution. At this point, adoptive immunotherapy by CMV-specific T-cells can control CMV infection or provide immune reconstruction. | en_US |
dc.identifier.citation | Celilova, S., Toret, E., Adakli Aksoy, B., Ovali, E., Bozkurt, C. (2020). CMV-specific T-Cells for Treatment of CMV infection after hematopoietic stem cell transplantation in a pediatric case: First application in Turkey. Turkish Journal of Hematology, 37(1), 57-76. | |
dc.identifier.doi | 10.4274/tjh.galenos.2019.2019.0293 | |
dc.identifier.endpage | 67 | en_US |
dc.identifier.issn | 1300-7777 | |
dc.identifier.issn | 1308-5263 | |
dc.identifier.issue | 1 | en_US |
dc.identifier.scopus | 2-s2.0-85080844385 | |
dc.identifier.scopusquality | Q3 | |
dc.identifier.startpage | 65 | en_US |
dc.identifier.trdizinid | 365186 | |
dc.identifier.uri | https://doi.org/10.4274/tjh.galenos.2019.2019.0293 | |
dc.identifier.uri | https://app.trdizin.gov.tr/makale/TXpZMU1UZzJOZz09 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12939/1264 | |
dc.identifier.volume | 37 | en_US |
dc.identifier.wos | WOS:000514819900015 | |
dc.identifier.wosquality | Q3 | |
dc.indekslendigikaynak | Web of Science | |
dc.indekslendigikaynak | Scopus | |
dc.indekslendigikaynak | TR-Dizin | |
dc.indekslendigikaynak | PubMed | |
dc.institutionauthor | Celilova, Sevil | |
dc.institutionauthor | Toret, Ersin | |
dc.institutionauthor | Aksoy, Başak | |
dc.language.iso | en | |
dc.relation.ispartof | Turkish Journal of Hematology | |
dc.relation.publicationcategory | Diğer | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Childhood | en_US |
dc.subject | Hematopoietic Stem Cell Transplant | en_US |
dc.subject | CMV | en_US |
dc.subject | Specific T-Cell | en_US |
dc.subject | Therapy | en_US |
dc.subject | Internal Medicine | en_US |
dc.subject | RC31-1245 | en_US |
dc.subject | Diseases Of The Blood And Blood-Forming Organs | en_US |
dc.subject | RC633-647.5 | en_US |
dc.title | CMV-specific T-Cells for treatment of CMV infection after hematopoietic stem cell transplantation in a pediatric case: first application in Turkey | |
dc.title.alternative | Pediatrik bir olguda HKHN sonrası CMV spesifik t hücre kullanımı: Türkiye’deki ilk uygulama | |
dc.type | Letter |